查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1996514

醫療設備契約製造市場：2026-2032年全球市場預測（依產品類型、服務類型、製程類型、材料類型及最終用途分類）

Medical Device Outsourced Manufacturing Market by Product Type, Service Type, Process Type, Material Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療設備契約製造市場價值將達到 388.6 億美元，到 2026 年將成長至 433.1 億美元，到 2032 年將達到 841.3 億美元，複合年成長率為 11.66%。

主要市場統計數據
基準年 2025 388.6億美元
預計年份：2026年 433.1億美元
預測年份：2032年 841.3億美元
複合年成長率 (%) 11.66%

醫療設備契約製造的策略演變及其對創新路徑和供應鏈韌性的決定性影響。

醫療設備契約製造正從單純的成本削減措施轉變為一種策略能力，透過創新管道和合規性來增強全球供應鏈的韌性。製造商不僅將生產活動，還擴大將複雜的工程設計、法規支援和端到端的供應物流給專業合作夥伴。這種轉變源自於醫療設備製造商在規模化生產、流程專業知識和合規性方面對外部供應商的依賴，同時他們也專注於臨床開發和市場策略等核心能力。

技術創新、更嚴格的監管以及永續發展壓力如何重塑醫療設備製造外包夥伴關係和供應商的競爭格局？

近年來，技術、監管和市場因素的綜合作用從根本上改變了醫療設備原始設備製造商 (OEM) 的外包製造方式。積層製造和精密數控加工技術的進步擴大了適合外包的產品範圍，使其能夠製造複雜形狀的產品、客製化患者植入，並縮短原型製作週期。同時，滅菌技術和物流能力的成熟，在確保產品品質一致性的同時，也為全球分散式生產系統提供了支援。

評估不斷變化的美國關稅措施對跨境採購、供應商合格和區域生產策略的營運和策略影響。

近期關稅體系的調整以及針對零件進口和成品的新關稅的訂定，進一步加劇了依賴跨境供應鏈的製造商的困境。為因應關稅變化，採購團隊正在重新審視供應商選擇標準，權衡貨物到貨的總成本、前置作業時間的可靠性以及合規負擔。因此，企業正在重新思考籌資策略，以在保持與關鍵市場和臨床試驗基地接近性的同時，有效管理關稅風險。

全面的細分洞察，展示了產品類型、服務提供、製造流程、材料選擇和最終用途背景如何影響供應商選擇和營運風險。

有效的細分分析需要清楚了解產品系列、服務範圍、製程能力、材料選擇和最終用途環境如何相互作用，從而確定外包的適用性和供應商的兼容性。產品類型的差異會影響監管管道和污染控制要求。例如，心臟和整形外科植入等醫療設備比許多牙科器械和外科器械需要更嚴格的金屬組織控制和認證。導管和管路涉及流體動態和生物相容性的考量，並與滅菌方法的選擇密切相關；而診斷設備則專注於植入元件和感測器的整合。

影響製造策略、合規體系和供應商能力發展的關鍵區域的區域趨勢和供應鏈考量。

區域趨勢對籌資策略至關重要，因為當地的監管要求、人事費用和物流基礎設施直接影響供應商的能力和產品上市時間。在美洲，接近性重要的臨床中心和成熟的監管管道有利於快速迭代開發高度複雜的設備，並促進與檢驗的契約製造建立深度夥伴關係。同時，對關鍵電子元件穩定供應的需求正在推動以本地為中心的策略，從而減少長途海運路線和海關不確定性的風險。

競爭考察和以能力為中心的公司洞察突顯了整合服務組合、利基市場專業化和產業重組如何重新定義供應商差異化。

領先的契約製造製造商和服務供應商正從多個方面實現差異化：整合設計驅動製造 (DFM)、滅菌和物流的一體化服務組合；投資於數位化品質體系，實現即時製程監控和可審核性；以及在積層製造和先進材料領域進行有針對性的能力建設。市場領導者正在實施標準化的合格手冊和跨站點認證通訊協定，以減少跨國生產帶來的摩擦，並加速產能擴張以應對不斷變化的市場需求。

為經營團隊提供切實可行的建議，以協調供應商策略、加強技術轉移實踐並加快數位化可追溯性，從而降低風險並保持創新。

經營團隊應優先考慮策略供應商細分，將核心產品與擁有良好監管合規記錄和材料專業知識的合作夥伴對接。對於複雜的植入和診斷系統，應要求供應商提供檢驗活動、滅菌相容性和上市後監測支援的綜合證據。同時，對於早期項目，應採用靈活的供應商名單，優先考慮快速原型製作和迭代設計變更，而非規模經濟。這兩種方法既能確保商業性供應的可靠性，又能維持創新速度。

採用穩健的混合研究途徑，結合相關人員訪談、標準審查和檢驗，檢驗供應商能力和供應鏈動態。

本摘要的分析是基於對醫療設備製造商和服務供應商的高級採購、品質和工程負責人進行的訪談，並結合了與監管和物流專家的專題討論。這些定性資訊與公開的監管指南、技術白皮書和企業資訊披露進行交叉檢驗，以核實能力聲明並檢驗反覆出現的營運挑戰。訪談通訊協定主要圍繞著供應商選擇標準、技術轉移經驗、滅菌策略以及對近期貿易政策變化的因應措施。

摘要強調了在醫療設備持續創新中，基於能力的外包、具有彈性的籌資策略和數位化透明度的策略必要性。

對於尋求平衡創新敏捷性、法規遵循和成本控制的醫療設備製造商而言，製造外包已成為一項至關重要的策略工具。先進的製造流程、不斷發展的滅菌方案以及精細的材料選擇之間的相互作用，要求原始設備製造商 (OEM) 將供應商關係視為觀點，根據產品的複雜性和生命週期階段匹配供應商的優勢。雖然監管和貿易環境進一步加劇了營運風險，但可以透過積極的風險評估、供應商多元化和合約保障來降低這些風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備契約製造市場：依產品類型分類

  • 心臟醫療設備
  • 導管和管
  • 牙科設備
  • 診斷設備
  • 整形外科植入
  • 手術器械

第9章：醫療設備契約製造市場：依服務類型分類

  • 組裝和包裝
    • 初級包裝
    • 二級包裝
  • 設計與開發
    • 概念開發
    • 技術分析
  • 後勤
    • 低溫運輸
    • 一般物流
  • 製造業
    • 契約製造
    • 大規模生產
  • 原型
    • 橋樑製造
    • 快速原型製作
  • 無菌
    • 電子束
    • 環氧乙烷
    • 伽瑪射線滅菌

第10章：醫療設備契約製造市場：依工藝類型分類

  • 積層製造
    • 電子束熔化
    • 熔融沈積成型
    • 選擇性雷射燒結
    • 立體光刻技術
  • 吹塑成型
  • CNC加工
  • 擠壓
  • 射出成型

第11章：醫療設備契約製造市場：依材料類型分類

  • 電子元件
    • 電路基板
    • 感應器
  • 金屬
    • 鋁
    • 防鏽的
    • 鈦
  • 塑膠
    • 聚碳酸酯
    • 聚乙烯
    • 聚丙烯
    • PVC
  • 矽
    • 高黏度矽
    • 液態矽

第12章：醫療設備契約製造市場：依最終用途分類

  • 門診部
  • 診所
  • 居家醫療
  • 醫院
  • 專業醫療中心

第13章：醫療設備契約製造市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：醫療設備契約製造市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：醫療設備契約製造市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療設備契約製造市場

第17章：中國醫療設備契約製造市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Benchmark Electronics, Inc.
  • Celestica Inc.
  • Flex Ltd.
  • Integer Holdings Corporation
  • Jabil Inc.
  • Kimball Electronics, Inc.
  • Nipro Corporation
  • Plexus Corp.
  • Sanmina Corporation
  • SMTC Corporation
  • TE Connectivity plc
  • Teleflex Incorporated
  • TT Electronics plc
  • West Pharmaceutical Services, Inc.
Product Code: MRR-FD3F12D53CF4

The Medical Device Outsourced Manufacturing Market was valued at USD 38.86 billion in 2025 and is projected to grow to USD 43.31 billion in 2026, with a CAGR of 11.66%, reaching USD 84.13 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 38.86 billion
Estimated Year [2026] USD 43.31 billion
Forecast Year [2032] USD 84.13 billion
CAGR (%) 11.66%

Framing the strategic evolution of outsourced manufacturing in medical devices and its decisive influence on innovation pathways and supply chain resilience

Outsourced manufacturing for medical devices has transitioned from a cost-driven tactic to a strategic capability that shapes innovation pipelines, regulatory outcomes, and the resilience of global supply chains. Manufacturers increasingly transfer not only production activities but also complex engineering, regulatory support, and end-to-end supply logistics to specialist partners. This shift is driven by device makers' focus on core competencies-such as clinical development and go-to-market strategy-while relying on external providers for scale, process expertise, and compliance infrastructure.

Consequently, contract manufacturers and service providers are expanding their technical portfolios to include advanced materials, additive manufacturing, and integrated sterilization processes. These providers are investing in digital twins, process analytics, and validation frameworks to meet stricter quality expectations and to reduce time-to-market for sophisticated implantables and diagnostic systems. As a result, procurement and product teams must navigate a more complex supplier ecosystem where technical capability, regulatory track record, and geographic footprint are equally important considerations.

This executive summary synthesizes the operational dynamics, regulatory headwinds, and commercial opportunities that characterize outsourced manufacturing for medical devices today. It highlights the transformative forces reshaping partnerships, analyzes the cumulative effects of new trade barriers, and translates segmentation- and region-level implications into tactical recommendations for executive decision-makers and functional leaders responsible for sourcing, quality, and product development.

How technological innovation, regulatory tightening, and sustainability pressures are reshaping outsourcing partnerships and supplier competitiveness in medical device manufacturing

The last several years have seen a confluence of technological, regulatory, and market forces that are fundamentally altering how device OEMs approach outsourced manufacturing. Advances in additive manufacturing and precision CNC machining have expanded the set of products that are viable for outsourcing, enabling complex geometries, patient-specific implants, and faster prototyping cycles. Meanwhile, sterilization technologies and logistics capabilities have matured to support globally distributed production with consistent quality outcomes.

Regulatory expectations have shifted toward tighter process control, more rigorous supplier oversight, and enhanced documentation for combination products and digital health-enabled devices. Consequently, contract manufacturers are integrating regulatory affairs expertise into their service offerings, enabling a smoother transfer of technical documentation and validation packages during new product transitions. At the same time, sustainability imperatives and circularity considerations are accelerating material substitution and waste-minimization practices within manufacturing operations.

From a commercial perspective, the competitive landscape is evolving: specialized providers that combine design-for-manufacturability support, scalable volume manufacturing, and end-to-end logistics are winning longer-term partnerships. In parallel, device makers are adopting hybrid sourcing models that blend strategic long-term agreements with agile, program-specific suppliers for rapid innovation cycles. Collectively, these shifts favor partners that can demonstrate integrated capabilities across product development, sterilization, regulatory support, and post-market surveillance, creating a new baseline for outsourcing relationships.

Assessing the operational and strategic consequences of evolving United States tariff measures on cross-border sourcing, supplier qualification, and regional production strategies

Recent adjustments to tariff regimes and the introduction of new duties affecting component imports and finished goods have introduced additional complexity for manufacturers dependent on cross-border supply chains. Tariff changes have prompted procurement teams to reevaluate supplier selection criteria, weighing the total landed cost of goods against lead-time reliability and regulatory compliance burdens. As a result, businesses are recalibrating sourcing strategies to manage customs exposure while preserving proximity to key markets and clinical study sites.

In response to trade policy shifts, internal stakeholders are assessing nearshoring and dual-sourcing strategies to mitigate single-source dependencies and to reduce the impact of tariff volatility. These approaches often require investments in qualification of alternate suppliers, transfer of process knowledge, and updating of supplier audit protocols. Moreover, some companies are accelerating technology transfers to regional manufacturing partners to avoid repeated customs duties on successive product iterations and to maintain tighter control over inventory and distribution.

The aggregate effect of these trade actions is a renewed focus on supply chain mapping, scenario planning, and contractual flexibility. Cross-functional teams are prioritizing harmonized product specifications and modular component designs that simplify supplier transitions. In addition, legal and commercial negotiators are including tariff-triggered repricing clauses and longer lead times for technology transfer into master services agreements to protect margins and ensure continuity of patient care delivery.

Comprehensive segmentation insights showing how product categories, service offerings, manufacturing processes, material choices, and end-use contexts drive supplier selection and operational risk

Effective segmentation analysis requires a clear understanding of how product portfolios, service scopes, process capabilities, material selection, and end-use contexts interact to determine outsourcing suitability and supplier fit. Product Type differentiation influences regulatory pathways and contamination control requirements; devices such as cardiology implants and orthopedic implants demand tighter metallurgical controls and more exacting certification than many dental devices or surgical instruments. Catheters and tubing introduce fluid dynamics and biocompatibility considerations that intersect with sterilization choices, while diagnostic equipment places a premium on electronic components and sensor integration.

Service Type distinctions determine where value is realized in an outsourced relationship. Providers that offer design and development services, including concept development and engineering analysis, can de-risk manufacturing transfers by resolving manufacturability and validation issues early. Assembly and packaging services that encompass both primary and secondary packaging create downstream efficiencies in labeling, serialization, and cold chain requirements. Logistics capabilities such as cold chain and general logistics are pivotal for temperature-sensitive diagnostics, and sterilization options-spanning e-beam, ethylene oxide, and gamma irradiation-must align with material compatibility and regulatory acceptance. Manufacturing modalities that range from bridge manufacturing and rapid prototyping to volume production require different quality systems and capital structures.

Process Type choices materially shape lead times, cost structures, and design freedom. Additive manufacturing modalities including electron beam melting, fused deposition modeling, selective laser sintering, and stereolithography enable patient-specific devices and consolidated assemblies but necessitate robust post-processing and traceability. Traditional processes such as injection molding, blow molding, extrusion, and CNC machining remain essential for high-volume polymeric and metallic components where tolerances and surface finishes are critical.

Material Type selection drives supplier capability needs and risk management priorities. Electronic components such as circuit boards and sensors require supply chain continuity and obsolescence management, while metals like aluminum, stainless steel, and titanium present differing machining and corrosion profiles. Plastic families, including polycarbonate, polyethylene, polypropylene, and PVC, must be evaluated for biocompatibility and sterilization resilience. Silicone formulations, whether high consistency or liquid silicone, offer soft-touch interfaces and sealing properties but demand specific molding and curing expertise.

End Use context also affects outsourcing decisions: hospitals and specialty centers expect equipment and implant reliability under rigorous clinical workflows, ambulatory care centers and clinics often prioritize compact, easy-to-use systems, and home healthcare scenarios require durable, user-friendly designs with simplified sterilization and maintenance pathways. Integrating these segmentation dimensions into supplier selection frameworks enables device makers to match technical requirements with operational capabilities, regulatory history, and geographic presence to optimize both development and lifecycle costs.

Regional dynamics and supply chain considerations across major territories that affect manufacturing strategy, compliance readiness, and supplier capability deployment

Geographic dynamics are central to sourcing strategy because regional regulatory expectations, labor costs, and logistics infrastructure directly affect supplier capabilities and time-to-market. In the Americas, proximity to major clinical centers and established regulatory pathways supports rapid iterations for high-complexity devices and fosters deep partnerships with contract manufacturers that have proven validation experience. Meanwhile, the need for secure supply of critical electronic components is shaping localized strategies that reduce exposure to long ocean freight lanes and customs uncertainty.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some subregions coexists with fragmented market access in others. Strong engineering talent pools and advanced materials suppliers in parts of Europe drive innovation in implantable devices and precision instruments, but manufacturers must reconcile differing national regulations and labeling requirements. In addition, logistical complexity across this broader region encourages multi-modal distribution plans and the use of regional quality hubs to centralize sterile storage and final assembly.

Asia-Pacific continues to be a source of scale manufacturing, advanced polymer processing, and a rapidly growing base of component suppliers. Rising domestic demand and expanding clinical infrastructures are enabling regionally based manufacturers to move up the value chain, offering both volume manufacturing and specialized processing such as high-precision injection molding and additive manufacturing services. Nevertheless, companies targeting Asia-Pacific markets must navigate variable regulatory frameworks and invest in supplier development to ensure consistent documentation, traceability, and compliance.

Competitive and capability-focused company insights highlighting how integrated service portfolios, niche specialization, and consolidation are redefining supplier differentiation

Leading contract manufacturers and service providers are differentiating along several axes: integrated service portfolios that combine design-for-manufacturing with sterilization and logistics; investments in digital quality systems that enable real-time process monitoring and auditability; and targeted capability builds in additive manufacturing and advanced materials. Market leaders are deploying standardized validation playbooks and cross-site qualification protocols to reduce the friction of multi-country production and to accelerate capacity scaling when demand shifts.

At the same time, mid-tier niche providers are gaining traction by specializing in particular product categories or technical capabilities, such as high-precision titanium processing for orthopedic implants or advanced polymer overmolding for diagnostic housings. These focused providers often offer greater agility during development phases, enabling rapid prototyping and iterative design adjustments that larger, volume-oriented suppliers may find harder to accommodate. Strategic partnerships between device innovators and these niche suppliers frequently include co-investments in equipment qualification and joint regulatory submissions to streamline commercialization.

Investor-backed and corporate-backed providers are also reshaping the supplier landscape through consolidation and cross-border expansions, bringing centralized compliance functions and standardized operating procedures to newly acquired sites. This trend is improving consistency for multinational manufacturers but also introduces integration risks related to culture, IT systems, and harmonized quality metrics. Ultimately, successful companies balance technical depth, regulatory competence, and commercial flexibility to meet the evolving needs of OEMs across product life cycles.

Actionable recommendations for executive teams to align supplier strategy, fortify technology transfer practices, and accelerate digital traceability to mitigate risk and sustain innovation

Executives should prioritize strategic supplier segmentation that aligns core products with partners possessing demonstrable regulatory experience and material expertise. For complex implants and diagnostic systems, require suppliers to present consolidated evidence of validation activities, sterilization compatibility, and post-market surveillance support. At the same time, adopt an agile supplier roster for early-stage programs where rapid prototyping and iterative design changes are more valuable than scale efficiencies. This dual approach preserves innovation velocity while safeguarding commercial supply reliability.

Operationally, organizations should invest in strengthened technology transfer playbooks that codify documentation standards, acceptance criteria, and escalation protocols, thereby reducing cycle time during supplier transitions. Cross-functional readiness-bringing together R&D, quality, procurement, and regulatory teams-will create smoother handoffs and ensure that all stakeholders share a single set of success metrics. In addition, introduce contractual mechanisms that address tariff volatility, material substitution, and capacity ramp milestones to provide commercial protections without stifling supplier investment.

Finally, leaders should accelerate digitalization initiatives that improve transparency across multi-tier supply chains. Implement end-to-end traceability systems, adopt manufacturing execution systems compatible with key suppliers, and use data-driven supplier scorecards that combine on-time delivery, quality performance, and responsiveness to change. These steps enable faster root-cause analysis during disruptions and support continuous improvement programs that enhance both product quality and cost predictability.

Robust mixed-methods research approach combining stakeholder interviews, standards review, and triangulation to validate supplier capabilities and supply chain dynamics

The analysis underpinning this summary synthesizes primary interviews with senior procurement, quality, and engineering leaders at device manufacturers and service providers, coupled with targeted discussions with regulatory and logistics experts. These qualitative inputs were triangulated with publicly available regulatory guidance, technical white papers, and company disclosures to validate capability claims and to map recurring operational challenges. Interview protocols focused on supplier selection criteria, technology transfer experiences, sterilization strategies, and responses to recent trade policy shifts.

Secondary research included systematic review of technical standards, sterilization validation methodologies, and process control frameworks relevant to device types such as implants, diagnostic equipment, and disposable consumables. Where applicable, capabilities were cross-referenced against documented audit outcomes and regulatory inspection trends to assess maturity levels among supplier cohorts. The methodology emphasized reproducibility through documented interview guides, source logs, and a validation loop in which draft findings were shared with subject matter experts for feedback and refinement.

Limitations of the approach are inherent to any cross-industry synthesis: rapidly evolving technologies and company-level strategic changes can alter capability footprints between research cycles. To address this, the study applied conservative interpretation thresholds when evaluating nascent technologies and incorporated scenario-based sensitivity checks to account for variability in supplier performance and geopolitical conditions.

Concluding synthesis underscoring the strategic imperative of capability-aligned outsourcing, resilient sourcing strategies, and digital transparency for sustained device innovation

Outsourced manufacturing has become an indispensable strategic tool for medical device companies seeking to balance innovation agility with regulatory compliance and cost management. The interplay of advanced manufacturing processes, evolving sterilization options, and nuanced material selections requires that OEMs approach supplier relationships with a portfolio mindset-matching supplier strengths to product complexity and life-cycle stage. Regulatory and trade environments add layers of operational risk that can be mitigated through proactive mapping, diversified sourcing, and contractual safeguards.

Looking ahead, the competitive advantage will accrue to organizations that combine rigorous supplier qualification, agile contracting, and investment in digital systems that provide real-time visibility into production and quality metrics. By treating outsourcing as a capability rather than a mere cost lever, device companies can accelerate innovation, improve patient outcomes through higher-quality products, and create more resilient supply networks that withstand policy and market shocks.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Outsourced Manufacturing Market, by Product Type

  • 8.1. Cardiology Devices
  • 8.2. Catheters And Tubing
  • 8.3. Dental Devices
  • 8.4. Diagnostic Equipment
  • 8.5. Orthopedic Implants
  • 8.6. Surgical Instruments

9. Medical Device Outsourced Manufacturing Market, by Service Type

  • 9.1. Assembly & Packaging
    • 9.1.1. Primary Packaging
    • 9.1.2. Secondary Packaging
  • 9.2. Design & Development
    • 9.2.1. Concept Development
    • 9.2.2. Engineering Analysis
  • 9.3. Logistics
    • 9.3.1. Cold Chain
    • 9.3.2. General Logistics
  • 9.4. Manufacturing
    • 9.4.1. Custom Manufacturing
    • 9.4.2. Volume Manufacturing
  • 9.5. Prototyping
    • 9.5.1. Bridge Manufacturing
    • 9.5.2. Rapid Prototyping
  • 9.6. Sterilization
    • 9.6.1. E-Beam
    • 9.6.2. Ethylene Oxide
    • 9.6.3. Gamma Irradiation

10. Medical Device Outsourced Manufacturing Market, by Process Type

  • 10.1. Additive Manufacturing
    • 10.1.1. Electron Beam Melting
    • 10.1.2. Fused Deposition Modeling
    • 10.1.3. Selective Laser Sintering
    • 10.1.4. Stereolithography
  • 10.2. Blow Molding
  • 10.3. CNC Machining
  • 10.4. Extrusion
  • 10.5. Injection Molding

11. Medical Device Outsourced Manufacturing Market, by Material Type

  • 11.1. Electronic Components
    • 11.1.1. Circuit Boards
    • 11.1.2. Sensors
  • 11.2. Metal
    • 11.2.1. Aluminum
    • 11.2.2. Stainless Steel
    • 11.2.3. Titanium
  • 11.3. Plastic
    • 11.3.1. Polycarbonate
    • 11.3.2. Polyethylene
    • 11.3.3. Polypropylene
    • 11.3.4. PVC
  • 11.4. Silicone
    • 11.4.1. High Consistency Silicone
    • 11.4.2. Liquid Silicone

12. Medical Device Outsourced Manufacturing Market, by End Use

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Home Healthcare
  • 12.4. Hospitals
  • 12.5. Specialty Centers

13. Medical Device Outsourced Manufacturing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Device Outsourced Manufacturing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Device Outsourced Manufacturing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Device Outsourced Manufacturing Market

17. China Medical Device Outsourced Manufacturing Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Benchmark Electronics, Inc.
  • 18.6. Celestica Inc.
  • 18.7. Flex Ltd.
  • 18.8. Integer Holdings Corporation
  • 18.9. Jabil Inc.
  • 18.10. Kimball Electronics, Inc.
  • 18.11. Nipro Corporation
  • 18.12. Plexus Corp.
  • 18.13. Sanmina Corporation
  • 18.14. SMTC Corporation
  • 18.15. TE Connectivity plc
  • 18.16. Teleflex Incorporated
  • 18.17. TT Electronics plc
  • 18.18. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HIGH CONSISTENCY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LIQUID SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LIQUID SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LIQUID SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (US